跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BIPRETERAX 8 mg/2,5 mg COMPRIMIDOS - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
BIPRETERAX 8 mg/2,5 mg COMPRIMIDOS
Approved
STANDARD
BIPRETERAX 8 mg/2,5 mg COMPRIMIDOS
Anpharm Przedsiebiorstwo Farmaceutyczne S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Dec 15, 2021
Approval ID
f6a8894f8016ef64
Company
Anpharm Przedsiebiorstwo Farmaceutyczne S.A.
Type
Standard
Approval Details
Approval Id
f6a8894f8016ef64
Drug Cima Aemps Name
BIPRETERAX 8 mg/2,5 mg COMPRIMIDOS
Register Number
OGYI-T-6831-02IP
Holder Company Name
Anpharm Przedsiebiorstwo Farmaceutyczne S.A.
Marketing Company Name
Melyfarma S.L.
Authorization Date
2021-12-15
Dosage Form
COMPRIMIDO
Dose
8 mg/2,5 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Anpharm Przedsiebiorstwo Farmaceutyczne S.A.
Active Ingredients
PERINDOPRIL ERBUMINA
8 mg
INDAPAMIDA
2,5 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Dec 15, 2021
Approval ID
f6a8894f8016ef64
Type
Standard
Back to CIMA-AEMPS Approvals